Literature DB >> 25171735

Refined regio- and stereoselective hydroxylation of L-pipecolic acid by protein engineering of L-proline cis-4-hydroxylase based on the X-ray crystal structure.

Kento Koketsu1, Yasuhito Shomura2, Kei Moriwaki1, Mikiro Hayashi1, Satoshi Mitsuhashi1, Ryotaro Hara3, Kuniki Kino3, Yoshiki Higuchi2.   

Abstract

Enzymatic regio- and stereoselective hydroxylation are valuable for the production of hydroxylated chiral ingredients. Proline hydroxylases are representative members of the nonheme Fe(2+)/α-ketoglutarate-dependent dioxygenase family. These enzymes catalyze the conversion of L-proline into hydroxy-L-prolines (Hyps). L-Proline cis-4-hydroxylases (cis-P4Hs) from Sinorhizobium meliloti and Mesorhizobium loti catalyze the hydroxylation of L-proline, generating cis-4-hydroxy-L-proline, as well as the hydroxylation of L-pipecolic acid (L-Pip), generating two regioisomers, cis-5-Hypip and cis-3-Hypip. To selectively produce cis-5-Hypip without simultaneous production of two isomers, protein engineering of cis-P4Hs is required. We therefore carried out protein engineering of cis-P4H to facilitate the conversion of the majority of L-Pip into the cis-5-Hypip isomer. We first solved the X-ray crystal structure of cis-P4H in complex with each of L-Pro and L-Pip. Then, we conducted three rounds of directed evolution and successfully created a cis-P4H triple mutant, V97F/V95W/E114G, demonstrating the desired regioselectivity toward cis-5-Hypip.

Entities:  

Keywords:  hydroxy-l-pipecolic acid; hydroxylation; hydroxyproline; proline hydroxylase; protein engineering

Mesh:

Substances:

Year:  2014        PMID: 25171735     DOI: 10.1021/sb500247a

Source DB:  PubMed          Journal:  ACS Synth Biol        ISSN: 2161-5063            Impact factor:   5.110


  8 in total

1.  Designing of an Efficient Whole-Cell Biocatalyst System for Converting L-Lysine Into Cis-3-Hydroxypipecolic Acid.

Authors:  Shewei Hu; Yangyang Li; Alei Zhang; Hui Li; Kequan Chen; Pingkai Ouyang
Journal:  Front Microbiol       Date:  2022-06-27       Impact factor: 6.064

Review 2.  Recent examples of α-ketoglutarate-dependent mononuclear non-haem iron enzymes in natural product biosyntheses.

Authors:  Shu-Shan Gao; Nathchar Naowarojna; Ronghai Cheng; Xueting Liu; Pinghua Liu
Journal:  Nat Prod Rep       Date:  2018-08-15       Impact factor: 13.423

3.  Structure of the ribosomal oxygenase OGFOD1 provides insights into the regio- and stereoselectivity of prolyl hydroxylases.

Authors:  Shoichiro Horita; John S Scotti; Cyrille Thinnes; Yousef S Mottaghi-Taromsari; Armin Thalhammer; Wei Ge; WeiShen Aik; Christoph Loenarz; Christopher J Schofield; Michael A McDonough
Journal:  Structure       Date:  2015-02-26       Impact factor: 5.006

4.  Studies on the selectivity of proline hydroxylases reveal new substrates including bicycles.

Authors:  Tristan J Smart; Refaat B Hamed; Timothy D W Claridge; Christopher J Schofield
Journal:  Bioorg Chem       Date:  2019-10-28       Impact factor: 5.275

Review 5.  Metabolic engineering strategy for synthetizing trans-4-hydroxy-L-proline in microorganisms.

Authors:  Zhenyu Zhang; Pengfu Liu; Weike Su; Huawei Zhang; Wenqian Xu; Xiaohe Chu
Journal:  Microb Cell Fact       Date:  2021-04-21       Impact factor: 5.328

Review 6.  Oxygenating Biocatalysts for Hydroxyl Functionalisation in Drug Discovery and Development.

Authors:  Sacha N Charlton; Martin A Hayes
Journal:  ChemMedChem       Date:  2022-05-02       Impact factor: 3.540

7.  Rational Design of the Soluble Variant of l-Pipecolic Acid Hydroxylase using the α-Helix Rule and the Hydropathy Contradiction Rule.

Authors:  Suguru Shinoda; Aoi Itakura; Haruka Sasano; Ryoma Miyake; Hiroshi Kawabata; Yasuhisa Asano
Journal:  ACS Omega       Date:  2022-08-11

8.  2-Ketoglutarate-Generated In Vitro Enzymatic Biosystem Facilitates Fe(II)/2-Ketoglutarate-Dependent Dioxygenase-Mediated C-H Bond Oxidation for (2s,3r,4s)-4-Hydroxyisoleucine Synthesis.

Authors:  Xiao-Ran Jing; Huan Liu; Yao Nie; Yan Xu
Journal:  Int J Mol Sci       Date:  2020-07-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.